Project cooperationUpdated on 21 January 2026
Urological Oncology and Tuberous Sclerosis Disease – Search for New Therapeutic Targets
International Projects Manager INiBICA at INiBICA – Institute for Biomedical Research of Cádiz
Cadiz, Spain
About
Line 1: Metastatic Castration‑Resistant Prostate Cancer (mCRPC) and urological tumors (kidney and bladder): study of the genetics and cell biology of the disease to identify new treatments targeting the process of ciliogenesis and the structure of the Primary Cilium.
Line 2: Identification of early detection biomarkers.
Line 3: Ciliopathies: application of advanced imaging tools to identify therapies for Leber Congenital Amaurosis (LCA) and other ciliopathies caused by mutations in the CEP290 gene.
Line 4: Tuberous Sclerosis (TS): use of next‑generation massive sequencing and advanced imaging techniques to identify new therapeutic targets that suppress the renal defects associated with TS.
Topic
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
Type
- Offering Expertise to Consortias
Similar opportunities
Project cooperation
PanGI Landmark Graph™ – Whole-Tract Capsule Intelligence
- Offering Expertise to Consortias
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
Miadreza Shafiekhah
Head of Research and Innovation at Nowocert
Dublin, Ireland
Project cooperation
CortexView Imaging Intelligence™ – AI-Enhanced Acquisition and Diagnosis
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
Miadreza Shafiekhah
Head of Research and Innovation at Nowocert
Dublin, Ireland
Project cooperation
OncoTwin 2030: AI‑Driven Digital Twin Platform for Oncology Decision Support
- Completing the consortia
- Offering Expertise to Consortias
- Design - setting the project scope
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
Dani Ortiz
representador legal at TORMENTA‑IA3, SL
Madrid, Spain